BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

959 related articles for article (PubMed ID: 19152896)

  • 21. Association between KRAS mutation, detected in pancreatic cyst fluid, and long-term outcomes of patients.
    Rockacy MJ; Zahid M; McGrath KM; Fasanella KE; Khalid A
    Clin Gastroenterol Hepatol; 2013 Apr; 11(4):425-9. PubMed ID: 23267865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.
    Singhi AD; McGrath K; Brand RE; Khalid A; Zeh HJ; Chennat JS; Fasanella KE; Papachristou GI; Slivka A; Bartlett DL; Dasyam AK; Hogg M; Lee KK; Marsh JW; Monaco SE; Ohori NP; Pingpank JF; Tsung A; Zureikat AH; Wald AI; Nikiforova MN
    Gut; 2018 Dec; 67(12):2131-2141. PubMed ID: 28970292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted cyst wall puncture and aspiration during EUS-FNA increases the diagnostic yield of premalignant and malignant pancreatic cysts.
    Hong SK; Loren DE; Rogart JN; Siddiqui AA; Sendecki JA; Bibbo M; Coben RM; Meckes DP; Kowalski TE
    Gastrointest Endosc; 2012 Apr; 75(4):775-82. PubMed ID: 22317883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
    Sadakari Y; Ienaga J; Kobayashi K; Miyasaka Y; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Pancreas; 2010 Mar; 39(2):232-6. PubMed ID: 19752768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts.
    Nikiforova MN; Khalid A; Fasanella KE; McGrath KM; Brand RE; Chennat JS; Slivka A; Zeh HJ; Zureikat AH; Krasinskas AM; Ohori NP; Schoedel KE; Navina S; Mantha GS; Pai RK; Singhi AD
    Mod Pathol; 2013 Nov; 26(11):1478-87. PubMed ID: 23743931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoscopic ultrasound-guided fine needle aspiration and cyst fluid analysis for pancreatic cysts.
    Attasaranya S; Pais S; LeBlanc J; McHenry L; Sherman S; DeWitt JM
    JOP; 2007 Sep; 8(5):553-63. PubMed ID: 17873459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data.
    Singhi AD; Zeh HJ; Brand RE; Nikiforova MN; Chennat JS; Fasanella KE; Khalid A; Papachristou GI; Slivka A; Hogg M; Lee KK; Tsung A; Zureikat AH; McGrath K
    Gastrointest Endosc; 2016 Jun; 83(6):1107-1117.e2. PubMed ID: 26709110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) contributes to a triple-negative test in preoperative screening of pancreatic cysts.
    Wu RI; Yoon WJ; Brugge WR; Mino-Kenudson M; Pitman MB
    Cancer Cytopathol; 2014 Jun; 122(6):412-9. PubMed ID: 24327575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing the multimodal approach to pancreatic cyst fluid diagnosis: developing a volume-based triage protocol.
    Chai SM; Herba K; Kumarasinghe MP; de Boer WB; Amanuel B; Grieu-Iacopetta F; Lim EM; Segarajasingam D; Yusoff I; Choo C; Frost F
    Cancer Cytopathol; 2013 Feb; 121(2):86-100. PubMed ID: 22961878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. K-ras mutations correlate with atypical cytology and elevated CEA levels in pancreatic cystic neoplasms.
    Mertz H
    Dig Dis Sci; 2011 Jul; 56(7):2197-201. PubMed ID: 21264513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine.
    Park WG; Wu M; Bowen R; Zheng M; Fitch WL; Pai RK; Wodziak D; Visser BC; Poultsides GA; Norton JA; Banerjee S; Chen AM; Friedland S; Scott BA; Pasricha PJ; Lowe AW; Peltz G
    Gastrointest Endosc; 2013 Aug; 78(2):295-302.e2. PubMed ID: 23566642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analysis of pancreatic cyst fluid: a comparative analysis with current practice of diagnosis.
    Shen J; Brugge WR; Dimaio CJ; Pitman MB
    Cancer; 2009 Jun; 117(3):217-27. PubMed ID: 19415731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyst fluid analysis obtained by EUS-guided FNA in the evaluation of discrete cystic neoplasms of the pancreas: a prospective single-center experience.
    Linder JD; Geenen JE; Catalano MF
    Gastrointest Endosc; 2006 Nov; 64(5):697-702. PubMed ID: 17055859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts.
    Yip-Schneider MT; Wu H; Dumas RP; Hancock BA; Agaram N; Radovich M; Schmidt CM
    J Am Coll Surg; 2014 Apr; 218(4):608-17. PubMed ID: 24491241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoprofile of mucinous non-neoplastic cyst of the pancreas.
    Zhu B; Lin X
    Appl Immunohistochem Mol Morphol; 2013 May; 21(3):265-70. PubMed ID: 22820665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Diagnostics in the Evaluation of Pancreatic Cysts.
    Theisen BK; Wald AI; Singhi AD
    Surg Pathol Clin; 2016 Sep; 9(3):441-56. PubMed ID: 27523971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyst wall puncture and aspiration during EUS-guided fine needle aspiration may increase the diagnostic yield of mucinous cysts of the pancreas.
    Rogart JN; Loren DE; Singu BS; Kowalski TE
    J Clin Gastroenterol; 2011 Feb; 45(2):164-9. PubMed ID: 20818233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Revisiting the performance of cyst fluid carcinoembryonic antigen as a diagnostic marker for pancreatic mucinous cysts: a comprehensive 20-year institutional review.
    Kwan MC; Pitman MB; Fernandez-Del Castillo C; Zhang ML
    Gut; 2024 Mar; 73(4):629-638. PubMed ID: 38195219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas.
    Kucera S; Centeno BA; Springett G; Malafa MP; Chen YA; Weber J; Klapman J
    JOP; 2012 Jul; 13(4):409-13. PubMed ID: 22797397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing.
    Majumder S; Taylor WR; Yab TC; Berger CK; Dukek BA; Cao X; Foote PH; Wu CW; Mahoney DW; Aslanian HR; Fernández-Del Castillo C; Doyle LA; Farrell JJ; Fisher WE; Lee LS; Lee YN; Park W; Rodrigues C; Gould Rothberg BE; Salem RR; Simeone DM; Urs S; Van Buren G; Smyrk TC; Allawi HT; Lidgard GP; Raimondo M; Chari ST; Kendrick ML; Kisiel JB; Topazian MD; Ahlquist DA
    Am J Gastroenterol; 2019 Sep; 114(9):1539-1549. PubMed ID: 31306149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.